ASSESSMENT OF ANEMIA CHARACTERISTICS DURING THE FIRST SIX MONTHS AFTER KIDNEY TRANSPLANTATION AND ASSOCIATED FACTORS IN PATIENTS UNDERGOING KIDNEY TRANSPLATATION AT MILITARY HOSPITAL 103

Bá Nghĩa Phan1, Lê Việt Thắng1, Nguyen Thi Thu Ha1,
1 Bệnh viện Quân y 103, Học viện Quân y

Main Article Content

Abstract

Objectives: To evaluate the prevalence of anemia during the first six months after kidney transplantation and its association with selected clinical and paraclinical characteristics in patients undergoing kidney transplantation. Methods: A combined retrospective and prospective study was conducted on 258 patients who successfully underwent kidney transplantation between January 2022 and January 2025 at Military Hospital 103. Anemia prevalence was assessed at 1 week, 1 month, 3 months, and 6 months post-transplant. Results: The prevalence of anemia progressively decreased from 92.24% at 1 week to 68.6% at 1 month, 39.53% at 3 months, and 23.26% at 6 months. Most cases were mild normocytic normochromic anemia; polycythemia was observed in 5.04% of patients. At 6 months post-transplant, female patients and those with an estimated glomerular filtration rate (eGFR) < 60 mL/min had significantly lower hemoglobin levels compared with other groups (p < 0.05). Patients’ age and post-transplant eGFR were independent predictors of anemia, with odds ratios of 0.97 and 0.96, respectively (p < 0.05). Conclusion: Anemia was highly prevalent during the first six months after kidney transplantation, although the prevalence decreased over time. At 6 months, anemia persisted in 23.26% of patients and was associated with female sex, reduced eGFR, and older age.

Article Details

References

1. Vanrenterghem Y, Ponticelli C, Morales JM, et al. Prevalence and management of anemia in renal transplant recipients: A European survey. American Journal of Transplantation. 2003; 3(7):835-845.
2. Jones H, Talwar M, Nogueira JM, et al. Anemia After kidney transplantation; its prevalence, risk factors, and independent association with graft and patient survival: A time-varying analysis. 2012; 93(9).
3. Fishbane S and Becker BN. Anemia and the kidney transplant recipient - UpToDate. Uptodate.
4. Tang Y, Guo J, Zhou J, et al. Risk factors and current state of therapy for anemia after kidney transplantation. Front Med. 2024; 10.
5. Bộ Y tế. Hướng dẫn chẩn đoán và điều trị một số bệnh lý huyết học. Nhà xuất bản Y học, Hà Nội. 2022:10-15.
6. Bia M, Adey DB, Bloom RD, et al. KDOQI US commentary on the 2009 KDIGO clinical practice guideline for the care of kidney transplant recipients. American Journal of Kidney Diseases. 2010; 56(2):189-218.
7. Nguyễn Anh Thư, Đỗ Gia Tuyền, Mai Thị Hiền. Tình trạng nhiễm virus BK ở bệnh nhân ghép thận tại Bệnh viện Bạch Mai. Tạp chí Nghiên cứu Y học. 2022; 160(12V2):180-189.
8. Radoui A, Skalli Z, Haddiya I, et al. Prevalence and predictive factors of anemia after renal transplantation: A Moroccan report. Transplant Proc. 2010; 42(9):3542-3549.
9. Pascual J, Jimenez C, Franco A, et al. Early-onset anemia after kidney transplantation is an independent factor for graft loss: A multicenter, observational cohort study. 2013; 96(8).
10. Zheng S, Coyne DW, Joist H, et al. Iron deficiency anemia and iron losses after renal transplantation. 2008.